✓ The New York Times ScienceScience & Systems
Richard Scolyer, Melanoma Expert Who Treated His Own Brain Tumor, Dies at 59
Australian melanoma researcher Richard Scolyer publicly documented his own brain tumor treatment, applying his cancer expertise to his own care, before dying at 59.
Richard Scolyer devoted his career to melanoma research in Australia, producing work described as lifesaving. When diagnosed with a brain tumor, his own scientific expertise illuminated the treatment he underwent, a journey he documented openly with the public.
His willingness to share the experience from inside the patient's role gave his final years a rare dual weight. He was 59.
Why it mattersHis experience as both leading oncologist and patient, documented openly, offers rare insight into how cancer research translates to individual treatment decisions.
Open this story in InSnip →
